| CRYSTAL STRUCTURE OF EBOLAVIRUS GLYCOPROTEIN IN COMPLEX WITH BEPRIDIL | |
Heteromer
| 32-632 | 99.59 | 3×NAG; 12×NAG; 15×GOL; 9×DMS; 3×CQN; |
|
| CRYSTAL STRUCTURE OF EBOLAVIRUS GLYCOPROTEIN IN COMPLEX WITH SERTRALINE | |
Heteromer
| 32-632 | 99.59 | 3×NAG; 12×NAG; 15×GOL; 3×SRE; 3×DMS; |
|
| CRYSTAL STRUCTURE OF EBOLAVIRUS GLYCOPROTEIN IN COMPLEX WITH benztropine | |
Heteromer
| 32-632 | 99.59 | 15×NAG; 15×GOL; 6×CXQ; 39×DMS; |
|
| CRYSTAL STRUCTURE OF EBOLAVIRUS GLYCOPROTEIN IN COMPLEX WITH PAROXETINE | |
Heteromer
| 32-632 | 99.59 | 3×NAG; 12×NAG; 3×DMS; 15×GOL; 3×8PR; |
|
| Crystal structure of Ebola glycoprotein in complex with ibuprofen | |
Heteromer
| 32-632 | 99.6 | 3×NAG; 12×NAG; 15×GOL; 3×IBP; |
|
| Crystal structure of Ebola glycoprotein in complex with toremifene | |
Heteromer
| 32-632 | 99.6 | 3×NAG; 12×NAG; 6×GOL; 3×DMS; 3×T0R; |
|
| Crystal structure of Ebolavirus glycoprotein in complex with inhibitor 118 | |
Heteromer
| 32-631 | 99.6 | 3×NAG; 15×NAG; 9×GOL; 6×GON; 3×DMS; |
|
| Crystal structure of Ebola glycoprotein | |
Heteromer
| 32-631 | 99.61 | 3×NAG; 15×NAG; 6×GOL; |
|
| Crystal structure of Ebolavirus glycoprotein in complex with imipramine | |
Heteromer
| 32-631 | 99.59 | 3×NAG; 12×NAG; 18×GOL; 6×IXX; 9×DMS; |
|
| Crystal structure of Ebolavirus glycoprotein in complex with inhibitor 118a | |
Heteromer
| 32-631 | 99.6 | 3×NAG; 15×NAG; 12×GOL; 6×GKZ; 3×DMS; |
|
| EM structure of a EBOV-GP bound to 3T0331 neutralizing antibody | |
Heteromer
| 32-631 | 99.59 | 3×NAG; 3×MAN; 3×NAG; |
|
| EM structure of a EBOV-GP bound to 4M0368 neutralizing antibody | |
Heteromer
| 32-631 | 99.59 | 3×NAG; 3×NAG; |
|
| Crystal Structure of Ebola zaire Envelope glycoprotein GP in complex with compound ARN0075146 | |
Heteromer
| 32-629 | 97.07 | 3×NAG; 12×NAG; 3×YOD; 6×GOL; |
|
| Crystal Structure of Ebola zaire Envelope glycoprotein GP in complex with compound ARN0075231 | |
Heteromer
| 32-628 | 99.57 | 3×NAG; 12×NAG; 3×ZQH; 3×EDO; 6×ACT; |
|
| Crystal Structure of Ebola zaire Envelope glycoprotein GP in complex with compound ARN0075093 | |
Heteromer
| 32-626 | 99.57 | 3×NAG; 12×NAG; 3×EDO; 6×ACT; 3×ZTL; |
|
| Crystal Structure of Ebola zaire Envelope glycoprotein GP in complex with compound ARN0074953 | |
Heteromer
| 32-622 | 97.46 | 3×NAG; 12×NAG; 3×YPS; |
|
| Crystal Structure of Ebola zaire Envelope glycoprotein GP in complex with compound ARN0075164 | |
Heteromer
| 32-622 | 97.48 | 3×NAG; 12×NAG; 9×EDO; 3×YPM; |
|
| Crystal structure of Ebola Zaire envelope glycoprotein GP in complex with compound ARN75092 | |
Heteromer
| 32-618 | 97.07 | 3×NAG; 12×NAG; 3×XJ5; 3×GOL; |
|
| Crystal Structure of Ebola zaire GP protein with bound ARN0074898 | |
Heteromer
| 32-618 | 99.57 | 3×NAG; 12×NAG; 15×GOL; 3×KHG; |
|
| Ebola virus glycoprotein in complex with EBOV-520 Fab | |
Heteromer
| 32-615 | 100 | 3×NAG; 3×GOL; |
|
| Structural Basis for Broad Neutralization of Ebolaviruses by an Antibody Targeting the Glycoprotein… | |
Heteromer
| 32-614 | 99.11 | 1×NAG; 2×NAG; |
|
| EBOV GP in complex with variable Fab domains of IgGs c2G4 and c13C6 | |
Heteromer
| 33-615 | 100.0 | 3×NAG; 3×NAG; 3×NAG; 3×NAG; 3×NAG; |
|
| EBOV GP in complex with variable Fab domains of IgGs c4G7 and c13C6 | |
Heteromer
| 33-615 | 100.0 | 3×NAG; 3×NAG; 3×NAG; |
|
| EBOV GP/Nanosota-EB1 | |
Heteromer
| 32-613 | 100.0 | 1×NAG; 1×NAG; 1×NAG; |
|
| EBOV GP/Nanosota-EB2 complex | |
Heteromer
| 32-613 | 100.0 | 1×NAG; 1×NAG; 1×NAG; 1×MAN; |
|
| Structure of the Inmazeb cocktail and resistance to escape against Ebola virus | |
Heteromer
| 32-613 | 100.0 | 3×NAG; 8×NAG; |
|
| Structure of EBOV GPcl in complex with the pan-ebolavirus mAb ADI-15878 | |
Heteromer
| 32-612 | 100 | 1×NAG; 2×NAG; 1×NAG; 2×NAG; |
|
| Structure of ZEBOV GP in complex with 1T0227 antibody | |
Heteromer
| 32-612 | 99.46 | 3×NAG; |
|
| Structure of ZEBOV GP in complex with 3T0265 antibody | |
Heteromer
| 32-612 | 99.46 | 3×NAG; |
|
| BDBV-289 bound to EBOV GPdMuc Makona | |
Heteromer
| 32-612 | 99.15 | 3×NAG; 9×NAG; |
|
| Structure of ZEBOV GP in complex with 5T0180 antibody | |
Heteromer
| 32-612 | 99.46 | 3×NAG; |
|
| Cleaved Ebola GP in complex with a broadly neutralizing human antibody, ADI-15946 | |
Heteromer
| 32-611 | 100 | 2×NAG; 1×NAG; |
|
| Crystal structure of the trimeric prefusion Ebola virus glycoprotein in complex with a neutralizing… | |
Heteromer
| 32-599 | 99.15 | 2×NAG; 2×NAG; 1×NAG; 1×NAG; |
|
| Crystal Structure of Protective Human Antibodies 100 and 114 in Complex with Ebola Virus Fusion Gly… | |
Heteromer
| 33-599 | 100 | |
|
| Structure of EBOV GP lacking the mucin-like domain with 1C11 scFv and 1C3 Fab bound | |
Heteromer
| 33-599 | 100.0 | 3×NAG; |
|
| EBOV GP bound to rEBOV-442 and rEBOV-515 Fabs | |
Heteromer
| 32-598 | 99.1 | 6×NAG; 3×NAG; 6×NAG; |
|
| Ebola virus GP (mucin deleted, Makona strain) bound to antibody Fab EBOV-293 | |
Heteromer
| 32-598 | 99.09 | 3×NAG; 3×NAG; 6×NAG; |
|
| Ebola virus GP (mucin deleted, Makona strain) bound to antibody Fab EBOV-296 and EBOV-515 | |
Heteromer
| 32-598 | 99.09 | 3×NAG; 9×NAG; |
|
| Ebola virus GP (mucin deleted, Makona strain) bound to antibody Fab EBOV-442 | |
Heteromer
| 32-598 | 99.1 | 6×NAG; 3×NAG; 6×NAG; |
|
| Ebola virus GP (mucin deleted, Makona strain) bound to antibody Fab EBOV-437 | |
Heteromer
| 32-597 | 99.13 | 3×NAG; 3×NAG; 9×NAG; |
|
| Structure of EBOV GP lacking the mucin-like domain with 2.1.1D5 scFv and 6D6 scFv bound | |
Heteromer
| 33-598 | 100.0 | 3×NAG; 3×NAG; |
|
| Structure of EBOV GP lacking the mucin-like domain with 9.20.1A2 Fab and 6D6 scFv bound | |
Heteromer
| 33-598 | 100.0 | 3×NAG; 3×NAG; |
|
| EBOV sGP in complex with variable Fab domains of IgGs c13C6 and BDBV91 | |
Heteromer
| 53-284 | 100 | |
|
| Crystal structure of host-primed Ebola virus GP, GPcl. | |
Heteromer P87666; | 32-189 | 100 | 3×NAG; |
|
| Crystal structure of EBOV glycoprotein with modified HR1c and HR2 stalk at 3.2 A resolution | | homo-6-mer | 33-637 | 99.61 | 3×NAG; 3×NAG; 6×NAG; 3×PO4; |
|
| Crystal structure of Ebolavirus glycoprotein in complex with clomipramine | | homo-6-mer | 32-631 | 99.59 | 3×NAG; 12×NAG; 12×GOL; 3×CXX; |
|
| Crystal structure of Ebolavirus glycoprotein in complex with thioridazine | | homo-6-mer | 32-631 | 99.59 | 3×NAG; 12×NAG; 12×GOL; 9×DMS; 3×RTZ; |
|
| Crystal structure of EBOV glycoprotein with modified HR2 stalk at 2.3A resolution | | homo-6-mer | 33-626 | 99.59 | 6×NAG; 3×NAG; 6×GOL; 3×NAG; 3×PO4; |
|
| Crystal Structure of Stabilized GP from Makona Variant of Ebola Virus | | homo-3-mer | 33-620 | 98.72 | 3×NAG; 3×NAG; |
|
| CORE STRUCTURE OF GP2 FROM EBOLA VIRUS | | homo-3-mer | 557-630 | 98.65 | 1×CL; |
|
| NMR Structure of the Complete Internal Fusion Loop mutant L529A/I544A from Ebolavirus GP2 at pH 5.5 | | monomer | 507-560 | 96.3 | |
|
| NMR Structure of the Complete Internal Fusion Loop from Ebolavirus GP2 at pH 5.5 | | monomer | 507-560 | 100 | |
|
| NMR Structure of the Complete Internal Fusion Loop from Ebolavirus GP2 at pH 7.0 | | monomer | 507-560 | 100 | |
|
| NMR Structure of Ebola fusion peptide in SDS micelles at pH 7 | | monomer | 524-539 | 100 | |
|